Arteris (AIP) shares were in focus after the company announced a new collaboration with MIPS, a GlobalFoundries company, to support physical AI computing platforms across automotive, robotics, and embedded computing markets.

The collaboration news arrives after a strong run in Arteris shares, with a 30 day share price return of 64.96% and a year to date share price return of 85.82%. The 1 year total shareholder return is 330.80% and the 3 year total shareholder return is more than 5x, suggesting momentum has been building around the story at a US$28.95 share price.

If this AI partnership has your attention, it could be a good moment to see what else is moving in the space and scan 34 AI small caps

With Arteris now at US$28.95, trading above the current analyst price target and posting very strong recent returns, the key question is whether investors are overpaying for AI excitement or whether the market is simply catching up to expectations for future growth.

Most Popular Narrative: 43% Overvalued

The most followed valuation narrative pegs Arteris’ fair value at $20.25, which sits well below the last close at $28.95, putting today’s price into sharp focus.

Revisions to discount rate inputs are cited as a supportive factor for valuation, as analysts reassess the risk profile and cash flow outlook reflected in their models.

Updated future P/E estimates in recent research are being used to justify a richer valuation, with bullish analysts arguing that the company’s earnings potential is not fully captured at prior multiples.

Want to see what sits behind that higher fair value bar? The narrative leans on brisk revenue expansion, rising margins, and a premium future earnings multiple. The exact mix of those inputs might surprise you.

Result: Fair Value of $20.25 (OVERVALUED)

However, this depends on Arteris managing rising R&D and field engineering costs while avoiding revenue shocks if large customers scale back or switch providers.

Next Steps

Given the mix of excitement and caution in this story, it makes sense to move quickly, review the full data set, and weigh both sides yourself using 1 key reward and 3 important warning signs.

Looking for more investment ideas?

If Arteris has you thinking more broadly about where to put fresh capital to work, it is worth scanning a few focused stock lists before the next move.

• Target income first by reviewing companies in the 13 dividend fortresses built for investors who want yield front and center.
• Hunt for quality at a discount by checking the 51 high quality undervalued stocks that filters for strong fundamentals and attractive pricing.
• Prioritize resilience by working through the 67 resilient stocks with low risk scores so potential downside is part of your process, not an afterthought.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.